From Innovation to Implementation: Technology Shaping Tomorrow’s Standard of Care Today A fitting theme for this year’s Pathology Technology Australia Congress, held on 27-28 May, which brought together leaders from pathology, diagnostics, healthcare,...
Genomics Finds Its Place in Australia’s Digital Health Conversation – 20-21 May We were delighted to attend the Digital Health Festival last week, joined by members of InGeNA’s Data and Technology Working Group and our newly appointed independent...
The story of Rosie, an eight-year-old Staffy cross Shar Pei from Sydney whose owner used AI and genomic sequencing to design a personalised mRNA cancer vaccine, captured global attention in early 2026. It is a genuinely remarkable case. It is also widely misread, and...
A research team at the Hong Kong University of Science and Technology has done something that was not supposed to be possible: they have flipped the fundamental logic of CRISPR gene editing. Published in Nature Biotechnology this month, the work by Professor Hsing...
Federal Budget 2026–27 — What It Means for Genomics and Precision Medicine The 2026–27 Federal Budget provides several positive signals for genomics and precision medicine in Australia, particularly across precision oncology, clinical trials, medicines access, digital...
